Literature DB >> 1947867

Cost evaluation of chronic schizophrenic patients during the first 3 years after the first contact.

M Moscarelli1, S Capri, L Neri.   

Abstract

This study was performed in Italy, where mental health care is largely provided by the Government-financed Italian National Health Service (INHS). Since 1978, outpatient services and psychiatric beds in general hospitals have replaced psychiatric hospitals, which have not been permitted to admit new patients. The direct costs of three cohorts of 20 chronic schizophrenic patients were evaluated according to incidence data for a 3-year period. The analysis focused in particular on services provided by public institutions. The average cost per patient during this period following first contact-admission was $9,612 (1989 U.S. dollars), which is low compared to costs in other countries. The cost distribution between inpatient and outpatient services was different from other studies and showed that, in Italy, hospital expenses covered approximately 50 percent of total direct INHS costs. The length of time between onset and first contact-admission showed a significant association (p less than 0.01) with INHS costs during the 3 years. A significant association (p less than 0.05) also was found between the Scale for the Assessment of Positive Symptoms (SAPS) global symptom "delusions" evaluated after 5 to 7 years and the average INHS costs during the 3 years of the study.

Entities:  

Mesh:

Year:  1991        PMID: 1947867     DOI: 10.1093/schbul/17.3.421

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  7 in total

Review 1.  Mental health care costs: paucity of measurement.

Authors:  P McCrone; S Weich
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-03       Impact factor: 4.328

2.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

3.  The delay between symptom onset and seeking professional treatment for anxiety and depressive disorders in a rural Australian sample.

Authors:  Amanda C Green; Caroline Hunt; Helen J Stain
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-11-25       Impact factor: 4.328

Review 4.  Symptom assessment in schizophrenic prodromal states.

Authors:  T J Miller; T H McGlashan; S W Woods; K Stein; N Driesen; C M Corcoran; R Hoffman; L Davidson
Journal:  Psychiatr Q       Date:  1999

5.  Overview and emerging trends.

Authors:  Sandeep Grover; Ajit Avasthi; Subho Chakrabarti; Paramanand Kulhara
Journal:  Indian J Psychiatry       Date:  2005-10       Impact factor: 1.759

6.  Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia.

Authors:  Matthew M Large; Olav Nielssen; Christopher James Ryan; Robert Hayes
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-11-30       Impact factor: 4.328

7.  Healthcare in schizophrenia: effectiveness and progress of a redesigned care network.

Authors:  Dong-Sheng Tzeng; Li-Chiu Lian; Chin-Un Chang; Chun-Yuh Yang; Gian-Tin Lee; Peter Pan; For-Wey Lung
Journal:  BMC Health Serv Res       Date:  2007-08-17       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.